Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis

Abstract

Prepubertal exposure to a pharmacological dose (500 mg kg(-1)) of the phyto-oestrogen genistein can reduce the incidence and multiplicity of carcinogen-induced mammary tumours in rats. However, such an exposure also disrupts the function of the hypothalamic-pituitary-gonadal axis, making it unsuitable for breast cancer prevention. We studied whether prepubertal exposure to genistein at a total body dose broadly comparable to the level typical of Oriental countries, approximately 1 mg kg(-1) body weight, affects mammary tumorigenesis. We also studied whether prepubertal exposure to zearalenone, a major source for phyto-oestrogens in the USA, influences breast cancer risk. Prepubertal rats were treated between postnatal days 7 and 20, with 20 microg (approximately 1 mg kg(-1) body weight) of either genistein or zearalenone. Zearalenone exposure significantly reduced both the incidence and multiplicity of mammary tumours induced by 7,12-dimethylbenz(a)anthracene (DMBA). Genistein exposure significantly reduced tumour multiplicity, but not tumour incidence, when compared with vehicle-treated animals. Furthermore, 60% of the tumours in the genistein group were not malignant, while all the tumours analysed for histopathology in the vehicle and zearalenone groups were adenocarcinomas. A higher number of differentiated alveolar buds, and lower number of terminal ducts, were present in the DMBA-treated mammary glands of the phyto-oestrogen exposed rats. The concentration of oestrogen receptor (ER) binding sites after the DMBA treatment was low in the mammary glands of all groups but a significantly higher proportion of the glands in the zearalenone exposed rats were ER-positive (i.e. ER levels > or = 5 fmol mg(-1) protein) than the glands of the vehicle controls. Our data suggest that a prepubertal exposure to a low dose of either zearalenone or genistein may protect the mammary gland from carcinogen-induced malignant transformation, possibly by increasing differentiation of the mammary epithelial tree.

References 54

1. 1.

   Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987;262(12):5592-5595.

   Not in our library

2. 2.

   Barnes S. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Treat. 1997;46(2-3):169-179.

   Not in our library10.1023/a:1005956326155

3. 3.

   Clark G. M., McGuire W. L. Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol. 1988;15(2 Suppl 1):20-25.

   Not in our library

4. 4.

   Clarke R., Dickson R. B., Lippman M. E. Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. Crit Rev Oncol Hematol. 1992;12(1):1-23.

   Not in our library10.1016/1040-8428(92)90062-u

5. 5.

   Clarke R. Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models. Breast Cancer Res Treat. 1997;46(2-3):255-278.

   Not in our library10.1023/a:1005938428456

6. 6.

   Collins B. M., McLachlan J. A., Arnold S. F. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids. 1997;62(4):365-372.

   Not in our library10.1016/s0039-128x(96)00246-2

7. 7.

   Ekbom A., Trichopoulos D., Adami H. O., Hsieh C. C., Lan S. J. Evidence of prenatal influences on breast cancer risk. Lancet. 1992;340(8826):1015-1018.

   Not in our library10.1016/0140-6736(92)93019-j

8. 8.

   Faber K. A., Hughes C. L. The effect of neonatal exposure to diethylstilbestrol, genistein, and zearalenone on pituitary responsiveness and sexually dimorphic nucleus volume in the castrated adult rat. Biol Reprod. 1991;45(4):649-653.

   Not in our library10.1095/biolreprod45.4.649

9. 9.

   Freireich E. J., Gehan E. A., Rall D. P., Schmidt L. H., Skipper H. E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966;50(4):219-244.

   Not in our library

10. 10.

    Fukutake M., Takahashi M., Ishida K., Kawamura H., Sugimura T., Wakabayashi K. Quantification of genistein and genistin in soybeans and soybean products. Food Chem Toxicol. 1996;34(5):457-461.

    Not in our library10.1016/0278-6915(96)87355-8

11. 11.

    Gotoh T., Yamada K., Yin H., Ito A., Kataoka T., Dohi K. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J Cancer Res. 1998;89(2):137-142.

    Not in our library10.1111/j.1349-7006.1998.tb00541.x

12. 12.

    Grodstein F., Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Joffe M., Rosner B., Fuchs C., Hankinson S. E., Hunter D. J. Postmenopausal hormone therapy and mortality. N Engl J Med. 1997;336(25):1769-1775.

    Not in our library10.1056/nejm199706193362501

13. 13.

    Grubbs C. J., Farnell D. R., Hill D. L., McDonough K. C. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone. J Natl Cancer Inst. 1985;74(4):927-931.

    Not in our library

14. 14.

    Hagler W. M., Tyczkowska K., Hamilton P. B. Simultaneous occurrence of deoxynivalenol, zearalenone, and aflatoxin in 1982 scabby wheat from the midwestern United States. Appl Environ Microbiol. 1984;47(1):151-154.

    Not in our library10.1128/aem.47.1.151-154.1984

15. 15.

    Hanfelt J. J. Statistical approaches to experimental design and data analysis of in vivo studies. Breast Cancer Res Treat. 1997;46(2-3):279-302.

    Not in our library10.1023/a:1005946614343

16. 16.

    Haslam S. Z. The ontogeny of mouse mammary gland responsiveness to ovarian steroid hormones. Endocrinology. 1989;125(5):2766-2772.

    Not in our library10.1210/endo-125-5-2766

17. 17.

    Hawrylewicz E. J., Huang H. H., Blair W. H. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr. 1991;121(10):1693-1698.

    Not in our library10.1093/jn/121.10.1693

18. 18.

    Hilakivi-Clarke L., Cho E., Raygada M., Kenney N. Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor alpha, and estrogen receptor antagonist ICI 182,780. J Cell Physiol. 1997;170(3):279-289.

    Not in our library10.1002/(sici)1097-4652(199703)170:3<279::aid-jcp9>3.0.co;2-l

19. 19.

    Hilakivi-Clarke L., Clarke R., Onojafe I., Raygada M., Cho E., Lippman M. A maternal diet high in n - 6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci U S A. 1997;94(17):9372-9377.

    Not in our library10.1073/pnas.94.17.9372

20. 20.

    Hilakivi-Clarke L., Stoica A., Raygada M., Martin M. B. Consumption of a high-fat diet alters estrogen receptor content, protein kinase C activity, and mammary gland morphology in virgin and pregnant mice and female offspring. Cancer Res. 1998;58(4):654-660.

    Not in our library

21. 21.

    Hirohata T., Shigematsu T., Nomura A. M., Nomura Y., Horie A., Hirohata I. Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan. Natl Cancer Inst Monogr. 1985;69:187-190.

    Not in our library

22. 22.

    Hsieh C. Y., Santell R. C., Haslam S. Z., Helferich W. G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998;58(17):3833-3838.

    Not in our library

23. 23.

    Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet. 1997;350(9083):990-994.

    Not in our library10.1016/s0140-6736(97)01339-1

24. 24.

    Kuiper-Goodman T. Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenone. Can J Physiol Pharmacol. 1990;68(7):1017-1024.

    Not in our library10.1139/y90-155

25. 25.

    Lee H. P., Gourley L., Duffy S. W., Estéve J., Lee J., Day N. E. Dietary effects on breast-cancer risk in Singapore. Lancet. 1991;337(8751):1197-1200.

    Not in our library10.1016/0140-6736(91)92867-2

26. 26.

    Lopez J., Ogren L., Verjan R., Talamantes F. Effects of perinatal exposure to a synthetic estrogen and progestin on mammary tumorigenesis in mice. Teratology. 1988;38(2):129-134.

    Not in our library10.1002/tera.1420380205

27. 27.

    Lu L. J., Broemeling L. D., Marshall M. V., Ramanujam V. M. A simplified method to quantify isoflavones in commercial soybean diets and human urine after legume consumption. Cancer Epidemiol Biomarkers Prev. 1995;4(5):497-503.

    Not in our library

28. 28.

    Luo Y., Yoshizawa T., Katayama T. Comparative study on the natural occurrence of Fusarium mycotoxins (trichothecenes and zearalenone) in corn and wheat from high- and low-risk areas for human esophageal cancer in China. Appl Environ Microbiol. 1990;56(12):3723-3726.

    Not in our library10.1128/aem.56.12.3723-3726.1990

29. 29.

    Martin P. M., Horwitz K. B., Ryan D. S., McGuire W. L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 1978;103(5):1860-1867.

    Not in our library10.1210/endo-103-5-1860

30. 30.

    McMichael-Phillips D. F., Harding C., Morton M., Roberts S. A., Howell A., Potten C. S., Bundred N. J. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr. 1998;68(6 Suppl):1431S-1435S.

    Not in our library10.1093/ajcn/68.6.1431s

31. 31.

    Messina M. J., Persky V., Setchell K. D., Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer. 1994;21(2):113-131.

    Not in our library10.1080/01635589409514310

32. 32.

    Michels K. B., Trichopoulos D., Robins J. M., Rosner B. A., Manson J. E., Hunter D. J., Colditz G. A., Hankinson S. E., Speizer F. E., Willett W. C. Birthweight as a risk factor for breast cancer. Lancet. 1996;348(9041):1542-1546.

    Not in our library10.1016/s0140-6736(96)03102-9

33. 33.

    Murrill W. B., Brown N. M., Zhang J. X., Manzolillo P. A., Barnes S., Lamartiniere C. A. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis. 1996;17(7):1451-1457.

    Not in our library10.1093/carcin/17.7.1451

34. 34.

    Nagasawa H., Yanai R., Shodono M., Nakamura T., Tanabe Y. Effect of neonatally administered estrogen or prolactin on normal and neoplastic mammary growth and serum estradiol-17 beta level in rats. Cancer Res. 1974;34(10):2643-2646.

    Not in our library

35. 35.

    Nelson J., Clarke R., Dickson G. R., van den Berg H. W., Murphy R. F. The effects of Mg2+ ions or EDTA on nuclear integrity and apparent subcellular distribution of unoccupied oestrogen receptors in breast cancer cells. J Steroid Biochem. 1986;25(5A):619-626.

    Not in our library10.1016/0022-4731(86)90003-8

36. 36.

    Nomura A., Henderson B. E., Lee J. Breast cancer and diet among the Japanese in Hawaii. Am J Clin Nutr. 1978;31(11):2020-2025.

    Not in our library10.1093/ajcn/31.11.2020

37. 37.

    Petrakis N. L., Barnes S., King E. B., Lowenstein J., Wiencke J., Lee M. M., Miike R., Kirk M., Coward L. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1996;5(10):785-794.

    Not in our library

38. 38.

    Russo J., Russo I. H. Biological and molecular bases of mammary carcinogenesis. Lab Invest. 1987;57(2):112-137.

    Not in our library

39. 39.

    Sanderson M., Williams M. A., Malone K. E., Stanford J. L., Emanuel I., White E., Daling J. R. Perinatal factors and risk of breast cancer. Epidemiology. 1996;7(1):34-37.

    Not in our library10.1097/00001648-199601000-00007

40. 40.

    Santell R. C., Chang Y. C., Nair M. G., Helferich W. G. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr. 1997;127(2):263-269.

    Not in our library10.1093/jn/127.2.263

Cited by papers we hold 2

• Phytoestrogens and Breast Cancer Prevention: Possible Mechanisms of Action · 2008
  No notice
• Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study · 2005
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.